SEC Form D filing
Mekiri Bio, Inc., 2025-10-16
An SEC Form D private-offering notice from Boston, MA, a $2,000,000 filer-stated offering target in Biotech. Filed 2025-10-16. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Mekiri Bio, Inc. Verified via SEC Form D
Filed 2025-10-16Filed to raise $2,000,000First money in 2025-08-25Raised so far $1,000,000HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- knownwell, inc., 2025-10-21, $26.1M, Needham, MA
- SPRUCE BIOSCIENCES, INC., 2025-10-17, $50M, South San Francisco, CA
- Corner Therapeutics, Inc., 2025-10-20, $16.8M, Watertown, MA
- Biovantix Biotechnology, Inc, 2025-10-17, $15M, Dover, DE
- AIScientists, Inc., 2025-10-17, $5M, Cambridge, MA
- Celestia Diagnostics Inc., 2025-10-16, $1.5M, Birmingham, AL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.